E Z Yakupov

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial

Zoltán Szakács, Yves Dauvilliers, V. I. Mikhaylov et al. · The Lancet Neurology · 2017 · 333 citations

Medicine, Pharmacology, Psychiatry +10

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 239 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Long-term safety and efficacy of teriflunomide

Paul O’Connor, Mark S. Freedman, Aaron Miller et al. · Neurology · 2016 · 126 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Chronic nonspecific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP)

N. N. Yakhno, M.V. Churyukanov, G. Yu. Evzikov et al. · Neurology neuropsychiatry Psychosomatics · 2019 · 102 citations · Full text

Medicine, Physical Medicine, Rehabilitation Medicine +16